Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis

被引:147
|
作者
Siqueira, E [1 ]
Schoen, RE [1 ]
Silverman, W [1 ]
Martini, J [1 ]
Rabinovitz, M [1 ]
Weissfeld, JL [1 ]
Abu Elmaagd, K [1 ]
Madariaga, JR [1 ]
Slivka, A [1 ]
机构
[1] PUH, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA
关键词
D O I
10.1067/mge.2002.125105
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Primary sclerosing cholangitis is a progressive cholestatic liver disease associated with cholangiocarcinoma. Brush cytology and serum tumor markers (carcinoembryonic antigen, carbohydrate antigen 19-9 [CA19-9]) have been used to diagnose cholangiocarcinoma, but there are few data comparing their effectiveness. Methods:The effectiveness of brush cytology, carcinoembryonic antigen, and CA19-9 for the diagnosis of cholangiocarcinoma was retrospectively studied by review of patients with primary sclerosing cholangitis. Receiver operator curves were used to identify cutoff points for carcinoembryonic antigen and CA19-9. Results: Of 692 patients with primary sclerosing cholangitis screened, adequate follow-up was obtained in 333, 44 (13%) of whom had a diagnosis of cholangiocarcinoma. Three hundred eighteen brush cytology specimens were obtained in 151 patients; serum carcinoembryonic antigen and CA19-9 levels were obtained in 144 and 55 patients, respectively. The overall sensitivity and specificity of brush cytology were, respectively, 46.4% (95% CI [27.5,64.5]) and 100% (95% CI [97.2, 1001). A carcinoembryonic antigen >5.2 ng/mL had a sensitivity of 68.0% (95% CI [47.5, 83.9]) and specificity of 81.5% (95% Cl [73.9,87.7]). A CA19-9 >180 U/mL had a sensitivity of 66.7% (95% Cl [34.9, 87.7]) and specificity of 97.7% (95% Cl [88.2, 99.9]). In the subset of patients in which all 3 tests were obtained, (n = 45, cholangiocarcinoma = 8) the combination of an abnormal carcinoembryonic antigen or CA19-9 had the highest sensitivity: 100% (95% Cl [65.1, 100.0]) with a specificity of 78.4% (95% Cl [63.1, 89.7]). The combination of a positive brush cytology or an abnormal CA19-9 had a sensitivity and specificity of, respectively, 87.5% (95% Cl [50.0, 99.4]) and 97.3% (95% Cl [86.2, 99.9]). Conclusions: Screening patients with primary sclerosing cholangitis for cholangiocarcinoma with CA19-9 and carcinoembryonic antigen is reasonable, but the ideal intervals at which to obtain these tests and the cost-effectiveness require further study.
引用
收藏
页码:40 / 47
页数:8
相关论文
共 50 条
  • [1] Cholangiocarcinoma in patients with primary sclerosing cholangitis
    Fung, Brian M.
    Tabibian, James H.
    [J]. CURRENT OPINION IN GASTROENTEROLOGY, 2020, 36 (02) : 77 - 84
  • [2] Primary sclerosing cholangitis and cholangiocarcinoma
    Lazaridis, Konstantinos N.
    Gores, Gregory J.
    [J]. SEMINARS IN LIVER DISEASE, 2006, 26 (01) : 42 - 51
  • [3] Cholangiocarcinoma in primary sclerosing cholangitis
    Abbas G.
    Lindor K.D.
    [J]. Journal of Gastrointestinal Cancer, 2009, 40 (1-2) : 19 - 25
  • [5] Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis - The promise of DNA methylation and molecular biomarkers
    Vedeld, Hege Marie
    Folseraas, Trine
    Lind, Guro Elisabeth
    [J]. JHEP REPORTS, 2020, 2 (05)
  • [6] Advances in the diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis
    Luna, Laura E. Moreno
    Gores, Gregory J.
    [J]. LIVER TRANSPLANTATION, 2006, 12 (11) : S15 - S19
  • [7] Cholangiocarcinoma Surveillance Recommendations in Patients with Primary Sclerosing Cholangitis
    Saca, Daniel
    Flamm, Steven L.
    [J]. CLINICS IN LIVER DISEASE, 2024, 28 (01) : 183 - 192
  • [8] Incidence or cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Pasha, TM
    Petz, J
    Ludwig, J
    Therneau, TM
    Benson, JT
    Malinchoc, M
    Dickson, ER
    Lindor, KD
    [J]. HEPATOLOGY, 1997, 26 (04) : 165 - 165
  • [9] Screening and Diagnosis of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis
    Jesudian, Arun B.
    Jacobson, Ira M.
    [J]. REVIEWS IN GASTROENTEROLOGICAL DISORDERS, 2009, 9 (02) : E41 - E47
  • [10] CHOLANGIOCARCINOMA COMPLICATING PRIMARY SCLEROSING CHOLANGITIS
    ROSEN, CB
    NAGORNEY, DM
    WIESNER, RH
    COFFEY, RJ
    LARUSSO, NF
    [J]. ANNALS OF SURGERY, 1991, 213 (01) : 21 - 25